Global Newborn Screening Market Insights 2017-2023 - Research and Markets

DUBLIN--()--The "Global Newborn Screening Market Insights, Opportunity, Analysis, Market Shares And Forecast 2017 - 2023" report has been added to Research and Markets' offering.

The global newborn screening market is estimated to grow with the CAGR of approx. 12% during the forecast period (2016 - 2023)

The factors that are influencing the growth of newborn screening market are increasing prevalence of newborn diseases, government support towards newborn child health, rising awareness for pediatric congenital heart disease and technological advancements in newborn screening. Currently, newborn screening (NBS) is the highest population-based genetic screening effort in the U.S. and is performed globally. The Centers for Disease Control and Prevention (CDC) has recognized newborn screening as 1 of the 10 major public health achievements in the U.S. during the first decade of the 21st century.

The newborn screening programs are intended to detect asymptomatic newborns, which are at greater risk for particular diseases from those who might not, utilizing DBS specimens gathered 24 to 72 hours later birth. Babies which are screened positive are speedily followed up by the diagnostic confirmation and suitable treatment provides to prevent premature death, mental retardation and various deleterious clinical outcomes. Developments in the technology and the growth of the acclaimed uniform NBS panel of diseases led to lifesaving treatment and involvement for minimum 12,000 additional newborns every year in the U.S. with selected genetic, endocrine disorders and hearing.

Key Topics Covered:

1. Introduction

2. Market Overview

3. Market Determinants

4. Market Segmentation

5. Competitive Landscape

6. Geographical Analysis

7. Company Profiles

  • AB Sciex Llc (U.S.)
  • Agilent Technologies, Inc. (U.S.)
  • Bio Tek Instruments, Inc. (U.S.)
  • Bio-Rad Laboratories, Inc. (U.S.)
  • Cardinal Health, Inc. (U.S.)
  • Ge Healthcare (Uk)
  • Masimo Corporation (U.S.)
  • Medtronic Plc (U.S.)
  • Natus Medical, Inc. (U.S.)
  • Neogen Labs Pvt. Ltd. (India)
  • Perkinelmer, Inc. (U.S.)
  • Thermo Fisher Scientific, Inc. (U.S.)
  • Triviron Healthcare Pvt. Ltd. (India)
  • Waters Corporation (U.S.)
  • Zen Tech S.A. (Belgium)

For more information about this report visit https://www.researchandmarkets.com/research/sjnp5w/global_newborn

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Diagnostics, Maternal and Neonatal Care

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Diagnostics, Maternal and Neonatal Care